title: PTCA of degenerated vein grafts: experience of two periods (1992-93 and 1996-97) in 780 patients.
authors.affiliation: Main Taunus Heart Institute, Bad Soden and Red Cross Hospital, Frankfurt, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Reifart
authors.forename: H
authors.initials: H
authors.lastname: Störger
authors.forename: F
authors.initials: F
authors.lastname: Schwarz
authors.forename: A
authors.initials: A
authors.lastname: Rabe
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000627:therapeutic use; D001807:Blood Vessel Prosthesis; D001026:Coronary Artery Bypass / Q000009:adverse effects / Q000706:statistics & numerical data; D003327:Coronary Disease / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006083:Graft Occlusion, Vascular / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011138:Polytetrafluoroethylene; D012086:Reoperation / Q000706:statistics & numerical data*; D012501:Saphenous Vein / Q000637:transplantation; D015607:Stents; D013988:Ticlopidine / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D011138:Polytetrafluoroethylene; D013988:Ticlopidine; D001241:Aspirin